Skip to Main Content

Paper Details

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Genes Chromosomes Cancer
10
2022
Author NameAffiliation
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Peter HorakCenter for Personalized Medicine (ZPM)
Peter Horak
Daniel KazdalInstitute of Pathology, University Hospital Heidelberg
Daniel KazdalGerman Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H)
Volker EndrisInstitute of Pathology, University Hospital Heidelberg
Michael Allg??uerInstitute of Pathology, University Hospital Heidelberg
Anna-Lena VolckmarInstitute of Pathology, University Hospital Heidelberg
Martina KirchnerInstitute of Pathology, University Hospital Heidelberg
Huriye Seker-CinInstitute of Pathology, University Hospital Heidelberg
Jan Budczies
Jan BudcziesGerman Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H)
Jan BudcziesInstitute of Pathology, University Hospital Heidelberg
Olaf NeumannInstitute of Pathology, University Hospital Heidelberg
Peter SchirmacherInstitute of Pathology, University Hospital Heidelberg
Peter SchirmacherCenter for Personalized Medicine (ZPM)
Peter Schirmacher
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Stefan Fr??hling
Stefan Fr??hlingCenter for Personalized Medicine (ZPM)
Albrecht Stenzinger
Albrecht StenzingerCenter for Personalized Medicine (ZPM)
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Albrecht StenzingerGerman Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H)
  • 1 - 24

Datasets